loading

Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.18%
4.1746
4.046 3.2823 8.0842 2.7291
Operating Income/Loss
3.18%
-4.1746
-4.046 -3.2823 -8.0842 -2.7291
Income/Loss From Continuing Operations Before Tax
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Income/Loss From Continuing Operations After Tax
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Net Income/Loss
3.14%
-4.1518
-4.0253 -3.2584 -8.0402 -2.6687
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2.02%
13.64
13.37 13.17 0.0445 13.14
Diluted Average Shares
2.02%
13.64
13.37 13.17 0.0445 13.14
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.25 -0.61 -0.20
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.25 -0.61 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):